Deals in Depth: February 2008
Executive Summary
February 2008 dealmaking highlights: Takeda increases biotechnology investment through 13-compound license from Amgen worth $640mm; Fujifilm diversifies into pharma by acquiring majority stake in Toyama Chemical for $1.1bn; and Bruker BioSciences buys fellow research tools company Bruker BioSpin for $976mm.